---
title: "Centessa Pharmaceuticals (CNTA.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/CNTA.US/norm.md"
symbol: "CNTA.US"
name: "Centessa Pharmaceuticals"
parent: "https://longbridge.com/zh-HK/quote/CNTA.US.md"
datetime: "2026-05-20T02:43:38.985Z"
locales:
  - [en](https://longbridge.com/en/quote/CNTA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CNTA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CNTA.US/norm.md)
---

# Centessa Pharmaceuticals (CNTA.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.5161 | -0.4660 | -0.4091 | -0.3766 | -0.1965 |
| ROE | -62.50% | -63.89% | -67.92% | -55.08% | -26.54% |
| 營業收入 | - | 0.0000 | - | - | 15.00M |
| 凈利潤 | -79.24M | -66.16M | -54.89M | -50.34M | -26.14M |
| 營業利潤 | -79.77M | -68.47M | -53.79M | -54.65M | -30.78M |
| 毛利率 | - | - | - | - | 100.00% |
| 凈利率 | - | - | - | - | -174.23% |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 641.76M | 687.50M | 448.30M | 492.13M | 527.85M |
| 權益乘數 | 1.32 | 1.30 | 1.49 | 1.43 | 1.37 |
| 每股凈資產 | 3.15 | 3.53 | 2.24 | 2.58 | 2.89 |
| 資產周轉率 | 0.0000 | 0.0237 | 0.0284 | 0.0337 | 0.0350 |
| 現金及短投 | 276.59M | 294.58M | 246.21M | 250.72M | 284.50M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 10.52M | 10.85M | 11.19M | 11.27M | 11.46M |
| 凈債務 | -158.03M | -176.20M | -127.95M | -132.58M | -166.51M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -72.22M | -55.81M | -58.31M | -22.45M | -57.25M |
| 投資現金流 | 42.71M | -218.13M | 61.95M | -39.95M | -222.39M |
| 融資現金流 | 30.47M | 283.40M | 3.44M | 1.60M | 3.09M |
| 自由現金流 | -44.24M | -32.68M | -38.84M | -7.07M | -53.94M |
| 現金流充裕率 | - | -507336.36% | -24919.66% | -17819.05% | - |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | - | -11000.00 | -234000.00 | -126000.00 | - |